LivaNova PLC

LIVN: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$73.00MbrpjnvPhxf

LivaNova Earnings: Competitor's Oxygenator Woes Fuel Strong Revenue Growth

Narrow-moat LivaNova reported robust third-quarter results that ran slightly ahead of our expectations on the top line, but our slight adjustments to our near-term estimates weren’t enough to materially shift our fair value estimate. The shares remain fairly valued, in our view.

Sponsor Center